Taking people in DenmarkPhase 2
Tests a treatment in adults with BRAF V600E colorectal cancer
Tests a new treatment in adults with BRAF V600E colorectal cancer.
Key facts
- Who runs it
- Rigshospitalet
- Where
- Aalborg, Copenhagen Oe, Hilleroed, and Odense C, DenmarkSee the 4 sites
- Registry title
- New Beacon
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 53 people, planned
- Started
- 23 Oct 2024
- Expected to end
- 1 Jan 2027
- Type of study
- Interventional
- Record updated
- 23 October 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with colorectal cancer that has a BRAF V600E change. The record gives no further details.
- Age
- 18 years or older
- Sex
- All sexes can join
- Biomarker or test result
- BRAF V600E mutation
Where in Denmark
- Aalborg University HospitalAalborg, DenmarkTaking people
- RigshospitaletCopenhagen Oe, DenmarkTaking people
- Nordsjaellands HospitalHilleroed, DenmarkTaking people
- Odense University HospitalOdense C, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Tests a treatment in adults with BRAF V600E colorectal cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 23 October 2024